The Latest SPAC News and Rumors: December 19, 2022
by Marlena Haddad on 2022-12-19 at 11:32am

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Hong Kong market regulator urges city to uphold rule of law, IPO market freeze sparks 80% drop in Nasdaq listings, and Grab takes cost-cutting measures 


Top Hong Kong Market Regulator Urges City to Uphold Rule of Law

Hong Kong’s status as an international financial center hinges on ensuring investors have confidence that the city follows the “conventional” rule of law in place in other global hubs and maintaining its special role as a bridge between the world and China, according to Ashley Alder, the outgoing top market regulator.

Alder noted that “SPACs were one of the phenomena which basically signaled the final bit of bull market. We were very aware of that. Given that there seemed to be an inevitable, unstoppable drive to create a SPAC regime, we ended up with one that was deliberately designed to detoxify it. Because the incentives and other features of SPACs, without that sort of framework, in my view, broadly works against public investors.”

READ

IPO market freeze sparks 80% drop in Nasdaq listings

Equity listings on the Nasdaq fell about 80% this year, as the appetite for new issues took a hit from extreme volatility in the stock market, sparked by the Federal Reserve’s war on inflation.

A total of 156 companies listed their shares on the bourse this year, raising nearly $15 billion in initial public offerings, a far cry from 743 firms that raised $180 billion in what was a blockbuster 2021, data from the exchange operator showed.

The year also saw a big drop in the listings of blank-check companies, as regulatory concerns and their free-falling share price seemed to have cooled Wall Street’s hottest investment trend of 2021. In total, 68 SPACs listed on the exchange in 2022, compared with 110 a year earlier.

READ

Grab cost-cutting measures necessary but uncertainties continue to loom, say analysts

The recent round of cost-cutting measures undertaken by super app company Grab (NASDAQ:GRAB), coming two-and-a-half years since it last executed a major retrenchment exercise, was a necessary move given the firm’s financial situation, said analysts.

Its move was the latest in a spate of cost-cutting measures by high-profile tech firms, some of which have laid off workers, with one analyst describing Grab’s decision as a “matter of survival”.

READ

 

The Latest SPAC News and Rumors: December 19, 2022
Recent Posts
by Nicholas Alan Clayton on 2025-07-01 at 7:51pm

Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....

by Nicholas Alan Clayton on 2025-07-01 at 7:47pm

Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....

by Nicholas Alan Clayton on 2025-07-01 at 7:19pm

1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...

by Nicholas Alan Clayton on 2025-07-01 at 3:49pm

D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...

by Nicholas Alan Clayton on 2025-07-01 at 11:33am

Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved